About EUSA | People | Portfolio | Partners & Investors | News | Site Map | Contact

Product Summary

Product Availability Description  
Erwinase®:
powder for solution for injection (Erwinia chrysanthemi L-asparaginase, crisantaspase)
Europe:
UK,
Austria,
Denmark,
Finland,
Germany,
Greece,
Ireland,
The Netherlands,
Norway,
Portugal,
Sweden
Rest of World:
Canada,
Egypt,
Hong Kong, Malaysia,
New Zealand,
Singapore,
South Korea, Thailand
Erwinase® is indicated for the treatment of Acute Lymphoblastic Leukaemia. Patients receiving treatment with L-asparaginase derived from Escherichia coli, who develop hypersensitivity to that enzyme, may be able to continue treatment with ERWINASE® as the enzymes are immunologically distinct.* erwinase
Rapydan®:
medicated plaster combines 70 mg/70 mg of two local anesthetic agents, lidocaine and tetracaine, with a patented heating component.

Europe:
UK
Germany,
Portugal,
Sweden,
The Netherlands

Rapydan® is indicated for surface anesthesia of the skin in connection with needle puncture in adults and children from 3 years of age, and in cases of superficial surgical procedures on normal intact skin in adults, and is effective after 30 minutes.*

Rapydan Patch
Collatamp®G:
antibiotic impregnated sponge

Key:
Drug
Medical Device

Europe:
UK
Austria
Belgium
Bulgaria
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
The Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Switzerland
Rest of World:
Argentina
Aruba
Australia
Brazil
Canada
Chile
Colombia
Dominican Republic
Dutch Island
Hong Kong
India
Iran
Jordan
Kuwait
Malaysia
Mexico
Nigeria
Oman
Peru
Russia
Singapore
South Africa
Saudi Arabia
South Korea
Turkey
United Arab Emirates
Yemen

Collatamp® G,
a lyophilized collagen sponge impregnated with the aminoglycoside antibiotic gentamicin, is indicated for the prevention and treatment of post-surgery infection.*
Collatamp®
Kidrolase®: powder for solution for injection
(Escherichia coli
L-asparaginase)

Europe:
Bulgaria,
Czech Republic,
France
Rest of World:
Algeria,
Argentina,
Canada,
Chile,
Colombia,
Ecuador,
Egypt,
Israel,
Lebanon,
Morocco,
Palestine,
Saudi Arabia,
Syria,
Uruguay

Kidrolase® is indicated in the treatment of Acute Lymphoblastic Leukaemia and some Non-Hodgkin’s Lymphoma.*

kidrolase
Fomepizole:
5 mg/mL,
concentrate for solution for infusion.
Europe:
Austria,
Belgium,
Finland,
Germany,
Iceland,
Ireland,
Luxembourg,
The Netherlands
Norway,
Sweden,

This specific pharmacological antidote is indicated for the treatment of ethylene glycol poisoning.*
This compound is commonly used in automotive coolants and antifreeze.*
fomepizole
Xenazine®:
25 mg, scored tablets (INN: tetrabenazine)
Europe:
France

Xenazine® was developed by Cambridge Laboratories (UK), and is indicated for the treatment of Huntington’s chorea.*

xenazine

 

 

Portfolio
Erwinase®
Rapydan®
Collatamp®
Kidrolase®
Fomepizole
Xenazine®

Product Summary

Pipeline

Business Development
Opportunities

 

 
Back to home page Disclaimer | Legal
Registered in England 4555273 Registered Office The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA